Eli Lilly (LLY) Oncology Pipeline and $1B Nvidia (NVDA) AI Partnership Signal Strong 2026 Growth
unknown
📅 Published: 2026-01-27 13:38
📰 Source: Yahoo
📝 Words: 56
📝 Article Content
Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA Breakthrough Therapy designation for sofetabart mipitecan. This status applies to the treatment of adults with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer whose disease has progressed despite prior therapies. […]
📄 Summary
Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA Breakthrough Therapy designation for sofetabart mipitecan. This status applies to the treatment of adults with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer whose disease has progressed despite prior therapies. […]
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-01-29 16:37:15
Updated At:
2026-01-29 16:37:15
Scraping Job ID:
N/A
Stock Mentions:
NVDA - NVIDIA Corporation
Relevance: N/A
LLY - Eli Lilly and Company
Relevance: N/A